Moderators of treatment efficacy in individualized metacognitive training for psychosis (MCT+)
Standard
Moderators of treatment efficacy in individualized metacognitive training for psychosis (MCT+). / Leanza, Letizia; Studerus, Erich; Bozikas, Vasilis P; Moritz, Steffen; Andreou, Christina.
In: J BEHAV THER EXP PSY, Vol. 68, 09.2020, p. 101547.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Moderators of treatment efficacy in individualized metacognitive training for psychosis (MCT+)
AU - Leanza, Letizia
AU - Studerus, Erich
AU - Bozikas, Vasilis P
AU - Moritz, Steffen
AU - Andreou, Christina
N1 - Copyright © 2020 Elsevier Ltd. All rights reserved.
PY - 2020/9
Y1 - 2020/9
N2 - BACKGROUND AND OBJECTIVES: Individualized Metacognitive Training (MCT+) is a manualized intervention designed to improve delusional severity by reducing delusion-associated cognitive biases such as jumping-to-conclusions. Increased interest in personalized medicine stipulates the identification of patients who are more likely to benefit from specialized interventions. The present study aimed to explore baseline moderators of MCT+ efficacy on delusions and overall positive symptoms in psychosis.METHODS: We analyzed data from a randomized rater-blind controlled trial, in which 92 patients with psychotic disorders and current or past delusions were randomly assigned to either MCT+ or CogPack®, a cognitive remediation software. Baseline moderator variables consisted of jumping-to-conclusions, cognitive insight, quality of life, self-esteem, selective attention, and patients' attitudes towards their symptoms. Linear mixed-effects models were applied to investigate specific moderators of MCT+ efficacy.RESULTS: In MCT+ relative to CogPack, presence of a jumping-to-conclusions bias, a lowered decision threshold, and low self-esteem were associated with larger improvements in delusional severity and/or overall positive symptoms over time. Subjective reasoning style and insight, as well as subjective attitudes towards psychosis, did not moderate the treatment efficacy of MCT+ relative to CogPack.LIMITATIONS: Participation of both treatment groups in group MCT as a part of standard care, possibly leading to additional effects on delusional severity.CONCLUSIONS: Patients with low self-esteem and those who are prone to jumping-to-conclusions seem to particularly benefit from MCT+. Our results can help inform clinical practice as they provide specific criteria for selecting patients for whom MCT+ is most appropriate.
AB - BACKGROUND AND OBJECTIVES: Individualized Metacognitive Training (MCT+) is a manualized intervention designed to improve delusional severity by reducing delusion-associated cognitive biases such as jumping-to-conclusions. Increased interest in personalized medicine stipulates the identification of patients who are more likely to benefit from specialized interventions. The present study aimed to explore baseline moderators of MCT+ efficacy on delusions and overall positive symptoms in psychosis.METHODS: We analyzed data from a randomized rater-blind controlled trial, in which 92 patients with psychotic disorders and current or past delusions were randomly assigned to either MCT+ or CogPack®, a cognitive remediation software. Baseline moderator variables consisted of jumping-to-conclusions, cognitive insight, quality of life, self-esteem, selective attention, and patients' attitudes towards their symptoms. Linear mixed-effects models were applied to investigate specific moderators of MCT+ efficacy.RESULTS: In MCT+ relative to CogPack, presence of a jumping-to-conclusions bias, a lowered decision threshold, and low self-esteem were associated with larger improvements in delusional severity and/or overall positive symptoms over time. Subjective reasoning style and insight, as well as subjective attitudes towards psychosis, did not moderate the treatment efficacy of MCT+ relative to CogPack.LIMITATIONS: Participation of both treatment groups in group MCT as a part of standard care, possibly leading to additional effects on delusional severity.CONCLUSIONS: Patients with low self-esteem and those who are prone to jumping-to-conclusions seem to particularly benefit from MCT+. Our results can help inform clinical practice as they provide specific criteria for selecting patients for whom MCT+ is most appropriate.
U2 - 10.1016/j.jbtep.2020.101547
DO - 10.1016/j.jbtep.2020.101547
M3 - SCORING: Journal article
C2 - 31980132
VL - 68
SP - 101547
JO - J BEHAV THER EXP PSY
JF - J BEHAV THER EXP PSY
SN - 0005-7916
ER -